Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/01/1993 | CN1079002A Chicken growth hormone gene and an expression thereof in E.coli |
12/01/1993 | CN1079001A Intersexual heterozygous phycomyces |
12/01/1993 | CN1079000A Induction of somatic embryogenesis in taxus, and the production of taxane-ring containing alkaloids therefrom |
11/30/1993 | US5266689 Eimeria maxima 165 rDNA probes |
11/30/1993 | US5266688 Polynucleotide sequence for production of glucose oxidase in recombinant systems |
11/30/1993 | US5266491 DNA fragment and expression plasmid containing the DNA fragment |
11/30/1993 | US5266490 Mammalian expression vector |
11/30/1993 | US5266489 Recombinant herpesviruses, in particular for the production of vaccines, process for preparing them, plasmids produced during this process and vaccines obtained |
11/30/1993 | US5266488 Troponin T gene promoter and derivatives thereof |
11/30/1993 | US5266483 Bacillus strain and insect pest controlling agent |
11/30/1993 | US5266477 Monoclonal antibodies which differentiate between native and modified porcine somatotropins |
11/30/1993 | US5266474 Balanced inducible transcription system |
11/30/1993 | US5266464 Antitumor |
11/30/1993 | US5266459 Mutants and genetic screening for glucocerebrosidase with DNA for amplification |
11/30/1993 | US5266317 Insect-specific paralytic neurotoxin genes for use in biological insect control: methods and compositions |
11/30/1993 | US5266314 Insecticide making use of viruses and preparation process thereof |
11/30/1993 | US5266313 Raccoon poxvirus as a gene expression and vaccine vector for genes of rabies virus and other organisms |
11/27/1993 | CA2096860A1 Humanized monoclonal antibodies |
11/27/1993 | CA2096497A1 Mycobacteria probes |
11/25/1993 | WO1993023572A1 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
11/25/1993 | WO1993023570A1 Oligonucleotides having conjugates attached at the 2'-position of the sugar moiety |
11/25/1993 | WO1993023569A1 Method and reagent for inhibiting viral replication |
11/25/1993 | WO1993023567A1 Method of judging pre-c mutation of hepatitis b virus |
11/25/1993 | WO1993023563A1 Loop structures |
11/25/1993 | WO1993023562A1 Chemical method for the analysis of dna sequences |
11/25/1993 | WO1993023557A1 Anti-receptor agents to the vitamin b12/transcobalamin ii receptor |
11/25/1993 | WO1993023553A1 Production of transgenics by joining regulatory and coding regions in vivo |
11/25/1993 | WO1993023552A1 Targeting gene expression to living tissue using jet injection |
11/25/1993 | WO1993023551A1 Co-ordinated inhibition of plant gene expression |
11/25/1993 | WO1993023550A2 Activation of oligomerizing receptors by using fused receptor ligands |
11/25/1993 | WO1993023549A2 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors |
11/25/1993 | WO1993023548A2 METHOD OF DETECTING TISSUE-SPECIFIC FK506 BINDING PROTEIN MESSENGER RNAs AND USES THEREOF |
11/25/1993 | WO1993023547A1 ENZYMATIC PROCESS FOR PRODUCTION OF S-6-METHOXY-α-METHYL-2-NAPHTHALENEACETIC ACID |
11/25/1993 | WO1993023546A1 Methods and compositions for increasing the sensitivity of a cell to a dna damaging agent |
11/25/1993 | WO1993023544A1 Fusion protein from feline leukaemia virus gp70 as vaccine |
11/25/1993 | WO1993023543A1 Clostridium perfringens vaccines |
11/25/1993 | WO1993023542A1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
11/25/1993 | WO1993023541A1 Hepatocyte growth factor variants |
11/25/1993 | WO1993023540A2 Improved methods for the preparation of endotoxin-binding proteins |
11/25/1993 | WO1993023539A1 RETINOBLASTOMA-ASSOCIATED PROTEIN 1 cDNA |
11/25/1993 | WO1993023538A1 Isolated protein receptors, antibodies which bind thereto, nucleic acid sequence coding therefor, and uses thereof |
11/25/1993 | WO1993023537A1 Chimeric multivalent protein analogues and methods of use thereof |
11/25/1993 | WO1993023536A1 Sub-units of nmda receptors, process for producing the same and their use |
11/25/1993 | WO1993023535A1 Human 5ht-1b receptor (serotonin receptor), process for preparing the same and its uses |
11/25/1993 | WO1993023534A1 Process for gene targeting and genome manipulations |
11/25/1993 | WO1993023533A1 Anti-neoplastic in vivo drug screen |
11/25/1993 | WO1993023532A1 VIRUS RESISTANT PLANTS CONTAINING INDUCIBLE CYTOTOXIC mRNAs |
11/25/1993 | WO1993023530A1 Novel protease |
11/25/1993 | WO1993023492A1 Fluorescent microparticles with controllable enhanced stokes shift |
11/25/1993 | WO1993023435A1 Antibody assay for amylin |
11/25/1993 | WO1993023434A2 Bpi-immunoglobulin fusion proteins |
11/25/1993 | WO1993023431A1 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
11/25/1993 | WO1993023429A1 Receptor-type tyrosine kinase-like molecules |
11/25/1993 | WO1993023423A1 Canine coronavirus s gene and uses therefor |
11/25/1993 | WO1993023422A1 Compositions and methods for vaccination against coronaviruses |
11/25/1993 | WO1993023421A1 Universal coronavirus vaccine |
11/25/1993 | WO1993023068A1 Platelet derived growth factor antagonists |
11/25/1993 | WO1993023063A1 Novel neutrophil inhibitors |
11/25/1993 | WO1993023057A1 Method and reagent for inhibiting cancer development |
11/25/1993 | WO1993020203A3 Stability-enhanced variants of parathyroid hormone |
11/25/1993 | WO1993019178A3 Peptides useful for inducing tolerance |
11/25/1993 | WO1993016178A3 Sequences characteristic of human gene transcription product |
11/25/1993 | WO1992019743A3 Hcv genomic sequences for diagnostics and therapeutics |
11/25/1993 | DE4316882A1 DNA contg. caffeine de-methylase gene - used in prodn. of 3-methyl-7-alkyl-xanthine cpds. by microbial demethylation of 1,3-di:methyl derivs. |
11/25/1993 | CA2135905A1 Serotonin receptor, preparation and use thereof |
11/25/1993 | CA2135749A1 Platelet derived growth factor antagonists |
11/25/1993 | CA2135646A1 Method and reagent for inhibiting viral replication |
11/25/1993 | CA2135643A1 Virus resistant plants |
11/25/1993 | CA2135606A1 Loop structures |
11/25/1993 | CA2135499A1 Method and reagent for inhibiting cancer development |
11/25/1993 | CA2135471A1 Receptor-type tyrosine kinase-like molecules |
11/25/1993 | CA2135408A1 Chimeric multivalent protein analogues and methods of use thereof |
11/25/1993 | CA2135390A1 Novel neutrophil inhibitors |
11/25/1993 | CA2135201A1 Universal coronavirus vaccine |
11/25/1993 | CA2134898A1 Compositions and methods for vaccination against coronaviruses |
11/25/1993 | CA2134326A1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
11/25/1993 | CA2118012A1 Hepatocyte growth factor variants |
11/25/1993 | CA2117893A1 Variant dimers for receptor activation |
11/25/1993 | CA2113437A1 Fusion protein from feline leukaemia virus gp70 as vaccine |
11/25/1993 | CA2113278A1 Antibody assay for amylin |
11/24/1993 | EP0571085A1 Stable isoforms of creatine kinase for standard markers and diagnosis |
11/24/1993 | EP0571049A1 Novel proteolytic enzymes and their use in detergents |
11/24/1993 | EP0570916A2 Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same |
11/24/1993 | EP0570787A2 Simple process for stable chromosomal gene-amplification |
11/24/1993 | EP0570554A1 Monoclonal antibody and antibody components elicited to a polypeptide antigen ground state |
11/24/1993 | EP0570509A1 Htlv-i and htlv-ii peptide antigens and methods |
11/24/1993 | EP0570506A1 NOVEL $i(BACILLUS THURINGIENSIS) ISOLATES |
11/24/1993 | EP0570496A1 Polymorphic dna markers in bovidae |
11/24/1993 | EP0570489A1 LIVER-STAGE-SPECIFIC PEPTIDE SEQUENCES OF $i(P. FALCIPARUM) BEARING EPITOPES CAPABLE OF STIMULATING THE T LYMPHOCYTES |
11/24/1993 | EP0570422A1 Stamen-specific promoters from corn |
11/24/1993 | EP0570371A1 Genomic mapping method by direct haplotyping using intron sequence analysis |
11/24/1993 | EP0532650A4 Method of inducing plant defense mechanisms |
11/23/1993 | US5264618 For transport of biological active agents into cells for viral agents or polynucleotides or immunogenic peptides |
11/23/1993 | US5264566 Method for in vitro oligonucleotide synthesis using H-phosphonates |
11/23/1993 | US5264558 Single-chain monellin analog as a low calorie protein sweetner |
11/23/1993 | US5264557 DNA segment for genes |
11/23/1993 | US5264554 Platelet cell adhesion molecule and variants thereof |
11/23/1993 | US5264550 Human anti-inflammatory phospholipase inhibitor protein |
11/23/1993 | US5264423 Phosphorothioate, methyl phosphonate, phosphorotriester and phosphodiester oligodeoxyribonucleotide analogs; antitumor agents |
11/23/1993 | US5264416 Interleukin-7 receptors |